UK Expects…The AAR Innovation Review To Be More Than A Few Silver Bullets
This article was originally published in Clinica
Enthusiasm surrounding the UK’s Accelerated Access Review (AAR), a program to speed innovative drugs, devices, diagnostics and digital products into usage in NHS England, was brought to a crescendo in early September. That was when AAR expert on medtech and external advisory group member John Jeans exhorted full participation in the online consultation on the AAR website.
Register for our free email digests: